BIG PHARMA EARNINGS WATCH: NOVARTIS, MERCK, ASTRAZENECA, BRISTOL MYERS SQUIBB AND SANOFI
Apr 26, 2024
Big Pharma Continues Raking in Big Profits and Expectation-Beating Revenue… Read More
© 2025 CSRXP- All Rights Reserved
Blog Posts
DOSE OF REALITY: NEW ANALYSES UNDERSCORE HOW BIG PHARMA’S EGREGIOUS PRICING OF WEIGHT LOSS DRUGS IS UNSUSTAINABLE
Apr 25, 2024
Two Reports Explore Cost for U.S. Patients and the U.S. Health Care System of… Read More
BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON
Apr 19, 2024
Big Pharma Giant Kicks Off Q1 Earnings After Hiking Prices More Than 40 Times… Read More
SECOND OPINION: BIG PHARMA’S OUT-OF-POCKET PLANS ON BRAND NAME INHALERS MAY BE DESIGNED TO FURTHER UNDERMINE COMPETITION
Apr 8, 2024
Big Pharma’s Announcements Designed to Deflect from Criticism and Scrutiny… Read More
Dose of Reality: CBO Confirms Big Pharma’s Egregious Prices on Weight Loss Drugs Are Unsustainable
Mar 22, 2024
CBO Says Cost to Taxpayers of Covering GLP-1 Medications Would Outpace Savings… Read More
THEN VS. NOW: PFIZER LATEST BIG PHARMA GIANT TO ACCIDENTALLY DEBUNK INDUSTRY’S OWN DOOM-AND-GLOOM INNOVATION RHETORIC
Mar 7, 2024
Big Pharma Exec Downplays “Modest” Drug Pricing Solutions That CEO… Read More
BIG PHARMA WATCH: BIG PHARMA SET NEW RECORD FOR OUT-OF-CONTROL LAUNCH PRICES IN 2023, UP 35 PERCENT FROM PREVIOUS YEAR
Feb 26, 2024
Median Price Set by Brand Name Drug Makers on New Treatments Climbs to… Read More
BIG PHARMA EARNINGS WATCH: ELI LILLY AND NOVO NORDISK
Feb 22, 2024
GLP-1 Weight-Loss Leaders “Blow Past” Wall Street Projections in Q4 2023,… Read More
BIG PHARMA EARNINGS WATCH: MERCK, BRISTOL MYERS SQUIBB AND ABBVIE
Feb 15, 2024
More Big Pharma Giants Report Earnings That Top Wall Street Expectations While… Read More
DOSE OF REALITY: BIG PHARMA CEOS FACE A RECKONING FROM LAWMAKERS AND EXPERTS ON ANTI-COMPETITIVE PRACTICES AND PRICE GOUGING
Feb 12, 2024
Patent Abuse Designed to Extend Monopolies, Block Competition and Keep Prices… Read More
BIG PHARMA EARNINGS WATCH: PFIZER & GLAXOSMITHKLINE
Feb 9, 2024
Big Pharma Giants Continue Q4 Earnings Besting Wall Street Expectations Pfizer… Read More
DOSE OF REALITY: BIG PHARMA BUILDING PATENT THICKETS DISCONNECTED FROM ACTUAL INNOVATION TO CREATE NEW MONOPOLIES ON GLP-1 WEIGHT LOSS DRUGS
Feb 8, 2024
JAMA Analysis Finds Patents for Active Ingredients for Weight Loss Drugs… Read More